Soad Abdel Hay

Dr. Soad Abdel Hay

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
HSHanaa M. Saleh
Hanaa M. Saleh
MEMagda M. El-Henawee
Magda M. El-Henawee
GRGamal H. Ragab
Gamal H. Ragab
SHSoad Abdel Hay
Soad Abdel Hay

20 December 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HMHeba Mousa
Heba Mousa
SHSoad Abdel Hay
Soad Abdel Hay
RSRagaa El Sheikh
Ragaa El Sheikh
AGAyman A. Gouda
Ayman A. Gouda
SESamar Abd El-Ghaffar
Samar Abd El-Ghaffar
MEMohamed Abd El-Aal
Mohamed Abd El-Aal

1 June 2022 in Royal Society Open Science
Verified
Journal Article
Open access
SHSoad Abdel Hay
Soad Abdel Hay
MEMagda Elhenawee
Magda Elhenawee
KMKhaled Maged
Khaled Maged
AIAdel Ibrahim
Adel Ibrahim
Angiotensin-converting enzyme inhibitors are one of the most widely used anti-hypertensive drugs which are used to reduce hypertension. In 2018, the United States Food and Drug Administration together with the European Medicine Agency declared the presence of carcinogenic nitrosamine impurities such as nitrosodiethylamine (NDEA) in some of the products, including valsartan (VLS) and losartan (LOS), and drugs' recall procedures were started. Thus, they should be controlled to be below the acceptable cancer risk level to ensure safety of the pharmaceutical products. Therefore, sensitive and reliable analytical methods were required for detection and quantitation of NDEA in bulk and finished drug products. Green analytical chemistry has received great interest to minimize the amount of organic solvents consumed without loss in chromatographic performance. A green and sensitive HPLC method was developed for the determination of NDEA in LOS and VLS using mobile phase of 0.02 M ammonium acetate adjusted to pH 7.2 and ethanol in gradient manner. Limits of detection and limits of quantification for NDEA were estimated to be 0.2 and 0.5 µg ml −1 , respectively. The standardized limits of NDEA impurity in drug substances were set as 0.56 ppm, which indicates the feasibility of its determination by the proposed conventional method without need for expensive instrumentations (e.g. MS/MS detectors) that are not found in most pharmaceutical quality control laboratories.

1 October 2020 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
Khaled AttalaKhaled Attala
Khaled Attala
MEMaya S. Eissa
Maya S. Eissa
MHMohamed A. Hasan
Mohamed A. Hasan
MEMagda M. El-Henawee
Magda M. El-Henawee
SHSoad Abdel Hay
Soad Abdel Hay

6 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
OAOsama Ahmed
Osama Ahmed
HEHany El-Bassossy
Hany El-Bassossy
HEHeba El-Sayed
Heba El-Sayed
SHSoad Abdel Hay
Soad Abdel Hay
Despite its proven efficacy in diverse metabolic disorders, quercetin (QU) for clinical use is still limited because of its low bioavailability. D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS) is approved as a safe pharmaceutical adjuvant with marked antioxidant and anti-inflammatory activities. In the current study, several QU-loaded self-nanoemulsifying drug delivery systems (SNEDDS) were investigated to improve QU bioavailability. A reversed phase high performance liquid chromatography (RP-HPLC) method was developed, for the first time, as a simple and sensitive technique for pharmacokinetic studies of QU in the presence of TPGS SNEDDS formula in rat plasma. The analyses were performed on a Xterra C18 column (4.6 × 100 mm, 5 µm) and UV detection at 280 nm. The analytes were separated by a gradient system of methanol and phosphate buffer of pH 3. The developed RP-HPLC method showed low limit of detection (LODs) of 7.65 and 22.09 ng/mL and LOQs of 23.19 and 66.96 ng/mL for QU and TPGS, respectively, which allowed their determination in real rat plasma samples. The method was linear over a wide range, (30–10,000) and (100–10,000) ng/mL for QU and TPGS, respectively. The selected SNEDDS formula, containing 50% w/w TPGS, 30% polyethylene glycol 200 (PEG 200), and 20% w/w pumpkin seed oil (PSO), showed a globule size of 320 nm and −28.6 mV zeta potential. Results of the pharmacokinetic studies showed 149.8% improvement in bioavailability of QU in SNEDDS relative to its suspension. The developed HPLC method proved to be simple and sensitive for QU and TPGS simultaneous determination in rat plasma after oral administration of the new SNEDDS formula.

1 March 2016 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
SHSoad Abdel Hay
Soad Abdel Hay
HHHisham Hashem
Hisham Hashem
AGAyman Gouda
Ayman Gouda
A novel, simple and robust high-performance liquid chromatography (HPLC) method was developed and validated for simultaneous determination of xipamide (XIP), triamterene (TRI) and hydrochlorothiazide (HCT) in their bulk powders and dosage forms. Chromatographic separation was carried out in less than two minutes. The separation was performed on a RP C-18 stationary phase with an isocratic elution system consisting of 0.03 mol L−1 orthophosphoric acid (pH 2.3) and acetonitrile (ACN) as the mobile phase in the ratio of 50:50, at 2.0 mL min−1 flow rate at room temperature. Detection was performed at 220 nm. Validation was performed concerning system suitability, limits of detection and quantitation, accuracy, precision, linearity and robustness. Calibration curves were rectilinear over the range of 0.195–100 μg mL−1 for all the drugs studied. Recovery values were 99.9, 99.6 and 99.0 % for XIP, TRI and HCT, respectively. The method was applied to simultaneous determination of the studied analytes in their pharmaceutical dosage forms.